Clincosm LogoSign in Get a demo

locally advanced or metastatic nsclc

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic NSCLC Trial in China (AK104, Tislelizumab, carboplatin)

Not yet recruiting
  • Locally Advanced or Metastatic NSCLC
  • Bengbu, Anhui, China
  • +61 more
Aug 10, 2023

Locally Advanced or Metastatic NSCLC Trial in Ohio City (PBF-1129)

Active, not recruiting
  • Locally Advanced or Metastatic NSCLC
  • Ohio City, Ohio
    Division of medical Oncology A450B Starling Loving Hall
Jan 24, 2023

Locally Advanced or Metastatic NSCLC Trial in Shanghai (WJ13404 tablets)

Recruiting
  • Locally Advanced or Metastatic NSCLC
  • WJ13404 tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Dec 14, 2022

Locally Advanced or Metastatic NSCLC Patients, Progressed From

Active, not recruiting
  • Locally Advanced or Metastatic NSCLC
    • Beijing, China
    • +16 more
    Dec 16, 2022

    Locally Advanced or Metastatic NSCLC Trial in Nanjing (Rifampicin; ASK120067, ASK120067;itraconazole)

    Completed
    • Locally Advanced or Metastatic NSCLC
    • Nanjing, Jiangsu, China
      Drum Tower Hospital of Nanjing University School of Medical
    Nov 20, 2022

    Locally Advanced or Metastatic NSCLC Trial in Seoul (Osimertinib 80 MG [Tagrisso])

    Completed
    • Locally Advanced or Metastatic NSCLC
    • Osimertinib 80 MG [Tagrisso]
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 22, 2021

    Locally Advanced or Metastatic NSCLC Trial in Hangzhou (ASK120067, ASK120067 in fed condition)

    Completed
    • Locally Advanced or Metastatic NSCLC
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital of Zhejiang University School of
    Apr 27, 2020

    Asia PDL1 Study Among NSCLC Patients

    Completed
    • Locally Advanced or Metastatic NSCLC
      • Guangzhou, Guangdong, China
      • +3 more
      Feb 27, 2018